We are unaware of published studies that have compared insulin sensitivity to glucose turnover between patients with biopsy-proven NASH and simple steatosis using the gold standard hyperinsulinemic euglycaemic clamp approach, and we therefore consider our results as novel information. This evidence concerns the gene INS and metabolic dysfunction-associated steatohepatitis.